Compounds > 1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol
Page last updated: 2024-08-26

1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol and Emesis

1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol has been researched along with Emesis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beningo, KA; Elliott, WL; Heffner, TG; Leopold, WR; Sebolt-Leopold, JS; Stier, MA; Suto, MJ; Vincent, PW; Wiley, JN1
Deacon, JM; Holliday, SB; Horwich, A; Peckham, MJ1

Trials

1 trial(s) available for 1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol and Emesis

ArticleYear
A toxicity and pharmacokinetic study in man of the hypoxic-cell radiosensitiser RSU-1069.
    The British journal of radiology, 1986, Volume: 59, Issue:708

    Topics: Adult; Aged; Clinical Trials as Topic; Humans; Kinetics; Middle Aged; Misonidazole; Nausea; Radiation-Sensitizing Agents; Vomiting

1986

Other Studies

1 other study(ies) available for 1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol and Emesis

ArticleYear
Pharmacologic/pharmacokinetic evaluation of emesis induced by analogs of RSU 1069 and its control by antiemetic agents.
    International journal of radiation oncology, biology, physics, 1992, Volume: 22, Issue:3

    Topics: Animals; Antiemetics; Dogs; Drug Evaluation; Imidazoles; Mice; Misonidazole; Nitroimidazoles; Ondansetron; Radiation-Sensitizing Agents; Vomiting

1992